<DOC>
	<DOCNO>NCT01201161</DOCNO>
	<brief_summary>The purpose study assess effect ranibizumab reduce intraoperative vitreous haemorrhage par plana vitrectomy , thus facilitate surgery improve anatomical functional result patient advanced proliferative diabetic retinopathy traction retinal detachment .</brief_summary>
	<brief_title>Ranibizumab Diabetic Traction Retinal Detachment</brief_title>
	<detailed_description />
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<mesh_term>Retinal Detachment</mesh_term>
	<mesh_term>Dissociative Disorders</mesh_term>
	<mesh_term>Ranibizumab</mesh_term>
	<mesh_term>Temazepam</mesh_term>
	<criteria>Macular traction retinal detachment last three month le secondary diabetic retinopathy . Massive vitreous hemorrhage prevent detailed posterior pole examination ; Previous intraocular surgery cataract surgery Hemodialysis , know bleeding disorder use anticoagulant drug aspirin Prothrombin time , partial thromboplastin time platelet count without normal limit History previous thromboembolic event</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Diabetic Retinopathy</keyword>
	<keyword>Retinal detachment</keyword>
	<keyword>Vitreous Hemorrhage</keyword>
	<keyword>Preoperative Ranibizumab</keyword>
	<keyword>par plana vitrectomy</keyword>
</DOC>